We represent the innovative pharmaceutical industry globally, with a focus on three priorities: innovation, equitable access, and ethics. #AlwaysInnovating
Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security.
#AlwaysInnovating
By the end of 2021, will have worked together to make an estimated 12 billion #COVID19 vaccine doses, enough to vaccinate every adult in the world. We now need to ensure these vaccines reach those who need them most.
No one is safe until everybody is. That’s why we committed to Five Steps to speed up #COVID19 vaccine equity:
💉 Dose sharing
⚙️ Optimize production
🚧 Call out trade barriers to be eliminated
🟢 Support country readiness
💡 Drive further innovation
📽️ bit.ly/2U6fIzs
Vaccines are an important tool in the battle against the #COVID19 pandemic. By choosing to get a vaccine, you are helping to protect yourself, your loved ones and those around you who may be more vulnerable to the disease. #TeamVaccinesteamvaccines.ifpma.org/abeda-story
Once #COVID19 vaccines are approved, independent health authorities continue to monitor their safety and effectiveness. And the people and the places that make the vaccines are also monitored for safety. #TeamVaccines Find out more at teamvaccines.ifpma.org/catherine-story
The people around the world who are working tirelessly on #COVID19 vaccines need them as much as we all do. They know that vaccines are one of the best ways to protect the people we love. #TeamVaccines#VaccinesWork Find out more at teamvaccines.ifpma.org
Equitable access requires more than the delivery of doses. To strive for #COVID19 vaccine equity, innovative biopharmaceutical companies are committed to prioritizing:
🌏Country Readiness
⚙️Equitable Distribution
💡Innovation
➡️ifpma.info/3p8XFp1
How does #trade policy help prioritize equitable access to #COVID19 vaccines? At a @TradeExperettes event, @IFPMA @kalhaua took the floor to explain the importance of a robust #IP system to support investment in R&D, highlighting the real bottlenecks in vaccine development.
Leaders made pledges to share #COVID19 vaccine doses. We now need to address technical and trade challenges to make sure countries are ready to deliver the doses.